Neuronetics (STIM) Change in Accured Expenses (2017 - 2026)

Neuronetics (STIM) has 10 years of Change in Accured Expenses data on file, last reported at $170000.0 in Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 104.84% year-over-year to $170000.0 in Q1 2026; TTM through Mar 2026 was $3.9 million, a 292.57% increase from a year earlier, with the FY2025 full-year figure at $257000.0, up 112.34% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $170000.0, down from $3.6 million in the prior quarter.
• Over the last five years, Change in Accured Expenses for STIM reached as high as $3.6 million in Q4 2025 and fell as low as -$7.7 million in Q1 2023.
• Historically, Change in Accured Expenses has averaged $159117.6 across 5 years, with a median of $1.2 million in 2023.
• Across the five-year window, Change in Accured Expenses tumbled 1618.12% in 2023 and surged 571.05% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at $3.3 million in 2022, then fell by 23.5% to $2.6 million in 2023, then slumped by 135.85% to -$917000.0 in 2024, then soared by 488.11% to $3.6 million in 2025, then tumbled by 95.22% to $170000.0 in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $170000.0 in Q1 2026, $3.6 million in Q4 2025, and -$1.1 million in Q3 2025.